DRW Securities LLC Buys New Position in Axon Enterprise, Inc. (NASDAQ:AXON)

DRW Securities LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 729 shares of the biotechnology company’s stock, valued at approximately $291,000.

A number of other large investors have also modified their holdings of AXON. PFG Investments LLC grew its position in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after purchasing an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC grew its holdings in shares of Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after buying an additional 26 shares during the last quarter. Mather Group LLC. increased its position in shares of Axon Enterprise by 3.7% in the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after acquiring an additional 27 shares during the period. King Luther Capital Management Corp raised its stake in Axon Enterprise by 0.3% in the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock worth $4,185,000 after acquiring an additional 34 shares during the last quarter. Finally, CWM LLC raised its stake in Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after acquiring an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $634.96 on Thursday. The firm has a market cap of $48.42 billion, a PE ratio of 162.65, a P/E/G ratio of 13.62 and a beta of 0.94. The business has a 50-day moving average price of $473.23 and a 200 day moving average price of $372.97. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $641.20.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Patrick W. Smith sold 75,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the sale, the chief executive officer now directly owns 2,970,366 shares of the company’s stock, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 260,256 shares of company stock worth $105,984,120 over the last three months. 5.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research reports. JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.